ClinicalTrials.Veeva

Menu

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Integra LifeSciences logo

Integra LifeSciences

Status

Completed

Conditions

Carotid Artery Stenosis

Treatments

Device: Sundt carotid shunt

Study type

Observational

Funder types

Industry

Identifiers

NCT03816202
C-SCS-001

Details and patient eligibility

About

The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between the ages of 18-80 years old
  • Have undergone carotid endarterectomy with any Integra Sundt™ carotid shunt on or before date of study initiation
  • Availability of records on post-operative imaging of the carotid artery either by carotid duplex ultrasound or angiogram

Exclusion criteria

  • Insertion of a carotid shunt at the site of an infection

Trial design

100 participants in 1 patient group

Sundt Carotid Shunt
Description:
Subject has undergone a endarterectomy procedure with the use of the Sundt Carotid Shunt.
Treatment:
Device: Sundt carotid shunt

Trial documents
2

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems